Sulaiman Al Habib H1 2021 profit up 47% to SAR 644 mln

Sulaiman Al Habib H1 2021 profit up 47% to SAR 644 mln

08/08/2021 Argaam Exclusive

View other reports

Dr. Sulaiman Al Habib Medical Group reported a net profit after Zakat and tax of SAR 644 million for the first half of 2021, a 47% increase, compared to SAR 438.9 million in the same period a year ago.

 

The company attributed the profit rise to 35.3% increase in revenues, driven by the growth in the hospital segment, due to rise in number of patients.

 

The company also cited 35.97% increase in EBITDA and 46.84% rise in net income for the profit growth.



Financials (M)

Item 6m 2020 6m 2021 Change‬
Revenues 2,546.35 3,446.00 35.3 %
Gross Income 759.71 1,100.44 44.8 %
Operating Income 461.92 689.36 49.2 %
Net Income 438.85 644.40 46.8 %
Average Shares 350.00 350.00 -
EPS (Riyals) 1.25 1.84 46.8 %

The company’s Q2 net profit after Zakat and tax increased by 69% year-on-year (YoY) to SAR 325 million due to 45.57% rise in revenues, higher net income by 69.26%, and 47.58% rise in EBITDA.

 

On a quarterly basis, Q2 net profit increased 2% due to higher revenue, which was not impacted by the seasonality factors.



Current Quarter Comparison (M)

Compared With The
Item Q2 2020 Q2 2021 Change‬
Revenues 1,203.01 1,751.21 45.6 %
Gross Income 359.86 551.02 53.1 %
Operating Income 203.31 339.73 67.1 %
Net Income 192.25 325.40 69.3 %
Average Shares 350.00 350.00 -
EPS (Riyals) 0.55 0.93 69.3 %


Financial results (Million)

Period Revenues Change Gross Income Change Net Income Change EPS(Riyal)
Q1 2012 - - - - - - -
Q2 2012 - - - - - - -
Q3 2012 - - - - - - -
Q4 2012 - - - - - - -
Q1 2013 - - - - - - -
Q2 2013 - - - - - - -
Q3 2013 - - - - - - -
Q4 2013 - - - - - - -
Q1 2014 - - - - - - -
Q2 2014 - - - - - - -
Q3 2014 - - - - - - -
Q4 2014 - - - - - - -
Q1 2015 - - - - - - -
Q2 2015 - - - - - - -
Q3 2015 - - - - - - -
Q4 2015 - - - - - - -
Q1 2016 - - - - - - -
Q2 2016 - - - - - - -
Q3 2016 - - - - - - -
Q4 2016 - - - - - - -
Q1 2017 - - - - - - -
Q2 2017 - - - - - - -
Q3 2017 - - - - - - -
Q4 2017 - - - - - - -
Q1 2018 1,169.41 - 361.40 - 216.53 - 0.62
Q2 2018 1,068.31 - 290.57 - 151.51 - 0.43
Q3 2018 1,145.35 - 354.30 - 207.93 - 0.59
Q4 2018 1,204.57 - 355.74 - 225.34 - 0.64
Q1 2019 1,227.90 5.0 % 404.20 11.8 % 234.08 8.1 % 0.67
Q2 2019 1,157.19 8.3 % 334.70 15.2 % 167.97 10.9 % 0.48
Q3 2019 1,226.74 7.1 % 348.97 (1.5 %) 198.00 (4.8 %) 0.57
Q4 2019 1,404.45 16.6 % 435.67 22.5 % 270.18 19.9 % 0.77
Q1 2020 1,343.34 9.4 % 399.85 (1.1 %) 246.60 5.3 % 0.70
Q2 2020 1,203.01 4.0 % 359.86 7.5 % 192.25 14.5 % 0.55
Q3 2020 1,623.91 32.4 % 558.89 60.2 % 298.80 50.9 % 0.85
Q4 2020 1,691.35 20.4 % 545.81 25.3 % 317.83 17.6 % 0.91
Q1 2021 1,694.79 26.2 % 549.42 37.4 % 319.00 29.4 % 0.91
Q2 2021 1,751.21 45.6 % 551.02 53.1 % 325.40 69.3 % 0.93

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
Q1 2012 - - -
Q2 2012 - - -
Q3 2012 - - -
Q4 2012 - - -
Q1 2013 - - -
Q2 2013 - - -
Q3 2013 - - -
Q4 2013 - - -
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 - - -
Q4 2014 - - -
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 29.69 % 21.84 % 17.47 %
Q1 2019 30.24 % 22.28 % 17.62 %
Q2 2019 30.60 % 22.42 % 17.64 %
Q3 2019 29.97 % 21.82 % 17.14 %
Q4 2019 30.37 % 22.40 % 17.35 %
Q1 2020 29.60 % 22.52 % 17.20 %
Q2 2020 29.83 % 23.35 % 17.52 %
Q3 2020 31.47 % 24.38 % 18.08 %
Q4 2020 31.81 % 24.44 % 18.01 %
Q1 2021 32.42 % 24.53 % 18.15 %
Q2 2021 32.61 % 24.54 % 18.65 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
Q1 2012 - - - -
Q2 2012 - - - -
Q3 2012 - - - -
Q4 2012 - - - -
Q1 2013 - - - -
Q2 2013 - - - -
Q3 2013 - - - -
Q4 2013 - - - -
Q1 2014 - - - -
Q2 2014 - - - -
Q3 2014 - - - -
Q4 2014 - - - -
Q1 2015 - - - -
Q2 2015 - - - -
Q3 2015 - - - -
Q4 2015 - - - -
Q1 2016 - - - -
Q2 2016 - - - -
Q3 2016 - - - -
Q4 2016 - - - -
Q1 2017 - - - -
Q2 2017 - - - -
Q3 2017 - - - -
Q4 2017 - - - -
Q1 2018 350.00 - - 11.82
Q2 2018 350.00 - - 12.26
Q3 2018 350.00 - - 12.86
Q4 2018 350.00 2.29 2.29 12.37
Q1 2019 350.00 2.34 2.34 12.43
Q2 2019 350.00 2.39 2.39 11.79
Q3 2019 350.00 2.36 2.36 12.36
Q4 2019 350.00 2.49 2.49 12.55
Q1 2020 350.00 2.52 2.52 13.25
Q2 2020 350.00 2.59 2.59 13.29
Q3 2020 350.00 2.88 2.88 13.74
Q4 2020 350.00 3.02 3.02 14.03
Q1 2021 350.00 3.22 3.22 14.33
Q2 2021 350.00 3.60 3.60 14.56

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
Q1 2012 - - -
Q2 2012 - - -
Q3 2012 - - -
Q4 2012 - - -
Q1 2013 - - -
Q2 2013 - - -
Q3 2013 - - -
Q4 2013 - - -
Q1 2014 - - -
Q2 2014 - - -
Q3 2014 - - -
Q4 2014 - - -
Q1 2015 - - -
Q2 2015 - - -
Q3 2015 - - -
Q4 2015 - - -
Q1 2016 - - -
Q2 2016 - - -
Q3 2016 - - -
Q4 2016 - - -
Q1 2017 - - -
Q2 2017 - - -
Q3 2017 - - -
Q4 2017 - - -
Q1 2018 - - -
Q2 2018 - - -
Q3 2018 - - -
Q4 2018 - - -
Q1 2019 - - -
Q2 2019 - - -
Q3 2019 - - -
Q4 2019 - - -
Q1 2020 21.77 21.77 4.14
Q2 2020 29.06 29.06 5.67
Q3 2020 33.48 33.48 7.01
Q4 2020 36.14 36.14 7.77
Q1 2021 38.48 38.48 8.65
Q2 2021 45.35 45.35 11.22

Business Segments (Million)

Compared With The
Period Hospitals Pharmacies Others
Q1 2018 970.00 189.00 10.00
Q2 2018 865.00 174.00 30.00
Q3 2018 908.00 175.00 62.00
Q4 2018 938.00 199.00 68.00
Q1 2019 999.00 208.00 21.00
Q2 2019 916.00 201.00 40.00
Q3 2019 984.00 203.00 40.00
Q4 2019 1,102.00 242.00 60.00
Q1 2020 1,053.00 237.00 53.00
Q2 2020 931.00 209.00 63.00
Q3 2020 1,272.00 261.00 91.00
Q4 2020 1,346.00 294.00 52.00
Q1 2021 1,320.00 313.00 62.00
Q2 2021 1,366.00 315.00 70.00

Analysts Estimates (Million)

Item Q2 2021 (e) Q2 2021 (a) Change‬
Average 324.13 325.40 0.39 %

Estimates vs Actual (Million)

Item Q2 2021 (e) Q2 2021 (a) Change
Riyad Capital 324.00 325.40 0.4 %
AlJazira Capital 323.20 325.40 0.7 %
OSOOL AND BAKHEET 334.30 325.40 (2.7) %
SNB Capital 315.00 325.40 3.3 %


Financial Ratios
Current
Market Cap (M Riyal) 100,380.00
Enterprise Value (EV) (M) 103,708.16
Shares Outstanding ((M)) 350.00
EPS ( Riyal) (TTM) 6.02
Book Value (BV) ( Riyal) 18.96
Par Value ( Riyal) 10.00
Adjusted P/E (Last12) 48.96
P/E (TTM) 47.63
Price/book 15.13
Return on Average Assets (%) (TTM) 13.8
Return on Average Equity (%) (TTM) 33.2
more

Share Price

Dr. Sulaiman Al Habib Medical Services Group
286.80
3.80 1.34 %

Dr. Sulaiman Al Habib Medical Services Group (SULAIMAN ALHABIB)

More

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.